Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Cyto-Mine Chroma enhances single-cell analysis with advanced multiplexing and assay flexibility, optimizing functional screening workflows for researchers.

Inadequate staffing in surgical wards linked to adverse outcomes

A new paper in the British Journal of Surgery, published by Oxford University Press, shows that nursing shortages result in longer hospital stays and worse

September 24, 2024

Eyenovia acquires US licencing rights for Formosa’s topical eye steroid – Pharmaceutical Technology

Formosa will receive up to $86m, in upfront and milestone-based payments. Image Credit: megaflopp / Shutterstock. Eyenovia has acquired the exclusive licencing and commercialisation rights

August 16, 2023

ABIM CEO Retirement Comes Amid Wave of Criticism

Richard Baron, MD, CEO of the American Board of Internal Medicine (ABIM) and staunch supporter of the controversial maintenance of certification (MOC) program, announced that

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.